Skip to content

Observational Study of Dental Outcomes in Head and Neck Cancer Patients

Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02057510
Acronym
ORARAD
Enrollment
613
Registered
2014-02-07
Start date
2014-02-01
Completion date
2020-01-28
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Disease, Head and Neck Cancer, Osteoradionecrosis, Xerostomia

Keywords

Head and Neck Cancer, Radiation Therapy

Brief summary

The purpose of this study is to measure the two-year rate of tooth loss in patients who have received external beam radiation therapy with curative intent for head and neck cancer. The study will also evaluate the sequelae of radiation therapy and oral complications that may occur as a result to receiving radiation therapy.

Detailed description

This is a prospective cohort study to document dental and other oral outcomes in patients who receive external beam radiation therapy with curative intent, as part of clinical care for a head and neck cancer. Five hundred and seventy-five participants will be enrolled. All study participants will receive a baseline oral examination prior to the start of radiation therapy. Follow-up examinations and data collection will be conducted at six-month intervals up to 2 years after the start of radiation therapy. The primary outcome will be the two-year rate of tooth loss. Secondary outcomes will include measures of dental caries, periodontal health, salivary flow, and exposed bone/osteoradionecrosis. The proposed research will provide more information to inform the community about the sequelae of Radiation Therapy (RT) in head and neck cancer patients, to refine current guidelines and to design future studies on the dental management of these patients.

Interventions

None listed

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER
National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
University of Minnesota
CollaboratorOTHER
UConn Health
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
Brigham and Women's Hospital
CollaboratorOTHER
NYU Langone Health
CollaboratorOTHER
University of North Carolina
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years and older; * Willing and able to provide signed and dated consent form; * Diagnosed with head and neck squamous cell carcinoma (SCC) or a salivary gland cancer (SGC), and intends to receive external beam radiation therapy (RT) with curative intent (tumor eradication), with or without concomitant chemotherapy; OR * Diagnosed with a non-SCC, non-SGC malignancy of the head and neck region, and intends to receive RT, with or without concomitant chemotherapy. The subject must be expected to receive at least 4500 cGy to one of the following sites: 1. base of tongue 2. buccal/labial mucosa 3. epiglottis 4. floor of mouth 5. gingiva/alveolar ridge 6. hard palate 7. hypopharynx 8. larynx 9. lip 10. mandible 11. maxilla 12. maxillary sinus 13. nasal cavity 14. nasopharynx 15. neck 16. oral cavity 17. oral tongue 18. oropharynx 19. paranasal sinus/orbit 20. parotid gland 21. pharynx 22. retromolar trigone 23. soft palate 24. sublingual gland 25. submandibular gland 26. tonsil; * At least 1 natural tooth remaining or expected to remain in the mouth after completion of the pre-RT dental extractions, if any; * Willing to comply with all study procedures; * Willing to participate for the duration of the study.

Exclusion criteria

* Receiving palliative RT; * History of prior curative RT to the head and neck region to eradicate a malignancy; * Incarcerated at time of screening; * Anything that would place the subject at increased risk or preclude the subject's full compliance with or completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
Tooth lossTwo YearsThe primary outcome measure is the two-year rate of tooth loss in patients who have received at least one session of external beam radiation therapy with curative intent for head and neck cancer. "Tooth loss" will be defined as a dental extraction that has been performed or recommended. Since dental extractions are often avoided in this population because of the increased risk of osteoradionecrosis (ORN), tooth loss will also include teeth having a dental procedure to avoid extraction of a tooth that would otherwise have been extracted if the individual had not received RT and teeth recommended for extraction that have not been treated. The following categories will constitute teeth that would otherwise be recommended for extraction: * non-restorable because of fracture or extent of caries; * amputated crown with root remaining; * uncontrolled or persistent periodontal or odontogenic infection.

Secondary

MeasureTime frameDescription
Incidence of exposed intraoral boneTwo YearsTwo year incidence of exposed intraoral bone, suggestive of ORN. This will be defined as exposed maxillary or mandibular bone with an avascular appearance in a quadrant that has received RT
Extraction complicationsWithin 14 days following procedureIncidence of post-extraction complications
Decayed, Missing or Filled Surfaces (DMFS) IndexBaseline, 24 monthsTwo year change in DMFS - Decayed, Missing or Filled Surfaces Index
Periodontal MeasuresBaseline, 24 monthsTwo year change in periodontal measures
Stimulated Salivary Flow RateBaseline, 18 months18 month changes in stimulated whole salivary flow rates
Trismus measureBaseline, 24 monthsTwo year change in mouth opening in mm
Topical fluoride use for caries preventionBaseline, 24 monthsTwo year use of fluoride to prevent new caries
Chronic Oral Mucositis IncidenceBaseline, 24 monthsTwo year chronic oral mucositis incidence
Quality of Life after Radiation TherapyBaseline, 24 monthsTwo year change in radiation therapy-specific quality of life measures
Oral Cancer Pain ScaleBaseline, 24 monthsTwo year change in pain scores as measured with the University of California at San Francisco (UCSF) oral cancer pain scale

Countries

United States

Contacts

STUDY_CHAIRMichael T Brennan, DDS, MHS

Wake Forest University Health Sciences

STUDY_CHAIRRajesh Lalla, DDS, PhD

University of Connecticut Health Center - School of Dental Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026